Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y

British Journal of Pharmacology

Volumn 120, Issue 7, 1997, Pages 1335-1343

  Bischoff, Angela ^a   Avramidis, Prodromos ^a   Erdbrügger, Wilhelm ^a   Münter, Klaus ^b   Michel, Martin C ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Knoll AG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

BIBP 3226; Diuresis; Natriuresis; Neuropeptide Y; Receptor subtypes; Renal blood flow

Indexed keywords

ALDOSTERONE; CREATININE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; RECEPTOR SUBTYPE; RENIN; ARGININE; DRUG DERIVATIVE; PEPTIDE; PEPTIDE YY; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM URINE LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE CLEARANCE; DIURESIS; DRUG POTENCY; FOOD INTAKE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; URINARY EXCRETION; ANIMAL; BLOOD FLOW; CLASSIFICATION; DRUG EFFECT; KIDNEY; PHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ANIMALS; ARGININE; KIDNEY; MALE; NEUROPEPTIDE Y; PEPTIDE YY; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; REGIONAL BLOOD FLOW;

EID: 0030615272     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701028     Document Type: Article

References (37)

1. ALLEN, J.M., RAINE, A.E.G., LEDINGHAM, J.G.G. & BLOOM, S.R. (1985). Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin. Sci., 68, 373-377.
2. AUBERT, J.F., BURNIER, M., WAEBER, B., NUSSBERGER, J., DIPETTE, D.J., BURRIS, J.F. & BRUNNER, H.R. (1988). Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. J. Pharmacol. Exp. Ther., 244, 1109 - 1115.
3. AUBERT, J.F., WALKER, P. GROUZMANN, E., NUSSBERGER, J., BRUNNER, H.R. & WAEBER, B. (1992). Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats. Clin. Exp. Pharmacol. Physiol., 19, 223 - 228.
4. 36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Regul. Pept., 52, 187 - 193.
5. BISCHOFF, A., ERDBRÜGGER, W., SMITS, J. & MICHEL, M.C. (1996). Neuropeptide Y enhances diuresis and natriuresis in anaesthetized rats independent from renal blood flow reductions. J. Physiol., 495, 525 - 534.
6. CONZE, D.B., SMITH, G.P & CORP, E.S. (1995). Peptide YY (3 36) stimulates robust feeding after fourth ventricular administration. The Physiologist, 38, A-251.
7. CORDER, R., VALLOTTON, M.B., LOWRY, P.J. & RAMAGE, A.G. (1989). Neuropeptide Y lowers plasma renin activity in the anaesthetized cat. Neuropeptides, 14, 111 - 114.
8. 1 receptor antagonist BIBP 3226, J. Pharmacol Exp. Ther., 275, 136 - 142.
9. 1 receptor antagonist: a review of its pharmacological properties. Recent Advances in the Development of Peptide Receptor Ligands. Regul. Pept. (in press).
10. DUMONT, Y., MARTEL, J.-C., FOURNIER, A., ST. PIERRE, S. & QUIRION, R. (1991). Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol., 38, 125 - 167.
11. ECHTENKAMP, S.F. & DANDRIDGE, P.F. (1989). Renal actions of neuropeptide Y in the primate. Am. J. Physiol., 256, F524 - F531.
12. FIRTH, J.D., RAINE, A.E.G. & LEDINGHAM, J.G.G. (1990). The mechanism of pressure natriuresis. J. Hypertens., 8, 97 - 103.
13. GEHLERT, D.R. (1994). Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci., 55, 551-562.
14. GERALD, C., WALKER, M.W., CRISCIONE, L., GUSTAFSON, E.L., BATZ-HARTMANN, C., SMITH, K.E., VAYSSE, P., DURKIN, M.M., LAZ, T.M., LINEMEYER, T.L., SCHAFFHAUSER, A.O., WHITEBREAD, S., HOFBAUER, K.G., TABER, R.I., BRANCHEK, T.A. & WEINSHANK, R.L. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168 - 171.
15. GUYTON, A.C. (1991). Blood pressure control-special role of the kidneys and body fluids. Science, 252, 1813-1816.
16. HACKENTHAL, E. (1985). Methodische Aspekte des Renin-Angiotensin-Systems. In: Lehrbuch der Hypertonie ed. Ganten D & Ritz E, (pp. 178-185). Schattauer-Verlag.
17. HACKENTHAL, E., AKTORIES, K., JAKOBS, K.H. & LANG, R.E. (1987). Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am. J. Physiol., 252, F543 - F550.
18. 1 receptor antagonist. J. Pharmacol Exp. Ther., 275, 1261-1266.
19. LEVINE, A.S. & MORLEY, J.E. (1984). Neuropeptide Y: A potent inducer of consummatory behaviour in rats. Peptides, 5, 1025 - 1029.
20. MICHEL, M.C. (1991). Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci., 12, 389 - 394.
21. MICHEL, M.C. GAIDA, W., BECK-SICKINGER, A.G., WIELAND, H.A., DOODS, H., DUERR, J., JUNG, G. & SCHNORRENBERG, G. (1992). Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype differentiating effects on affinity and intrinsic efficacy. Mol. Pharmacol., 42, 642 648.
22. MICHEL, M.C. & RASCHER, W. (1995). Neuropeptide Y: a possible role in hypertension? J. Hypertens., 13, 385 - 395.
23. MINSON, R., MCRITCHIE, R. & CHALMERS, J. (1989). Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J. Autonom. Nerv. Syst., 27, 139 - 146.
24. MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1991). Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur. J. Pharmacol., 203, 165-171.
25. NERI, G., ANDREIS, P.G. & NUSSDORFER, G.G. (1990). Effects of neuropeptide Y and substance P on the secretory activity of dispersed zona-glomerulosa cells of rat adrenal gland. Neuropeptides, 17, 121 - 125.
26. OELLERICH, W.F. & MALIK, K.U. (1993). Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther., 266, 1321 - 1329.
27. PERNOW, J. & LUNDBERG, J.M. (1989). Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig. Acta Physiol. Scand., 136, 507 - 517.
28. PERSSON, P.B., EHMKE, H., NAFZ, B., LANG, R., HACKENTHAL, E., NOBILING, R., DIETRICH, M.S. & KIRCHHEIM, H.R. (1991). Effects of neuropeptide Y on renal function and its interaction with sympathetic stimulation in conscious dogs. J. Physiol., 444, 289 - 302.
29. A receptor-mediated responses to endothelin-1 in the rat kidney. Br. J. Pharmacol., 111, 729 - 732.
30. RIEB, M., BOHMANN, C., SCHAIBLE, U., MICHEL, M.C. & RUMP, L.C. (1995). Pre- and postjunctional effects of neuropeptide Y in human and rabbit isolated tissues. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, (Suppl.), R139.
31. SMITS, J.F.M., KASBERGEN, C.M., VAN ESSEN, H., KLEINJANS, J.C. & STRUYKER-BOUDIER, H.A.J. (1983). Chronic local infusion into the renal artery of unrestrained rats. Am. J. Phvsiol., 244, H304 - H307.
32. SMYTH, D.D., BLANDFORD, D.E. & THOM, S.L. (1988). Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat. Eur. J. Pharmacol., 152, 157 - 162.
33. STANLEY, B.G. & LEIBOWITZ, S.F. (1984). Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci., 35, 2635 - 2642.
34. STANLEY, B.G., DANIEL, D.R., CHIN, A.S. & LEIBOWITZ, S.F. (1985). Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides, 6, 1205-1211.
35. 1 receptor mediating this peptide's effect. Peptides, 13, 581 - 587.
36. WIELAND, H.A., WILLIM, K. & DOODS, H.N. (1995). Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides, 16, 1389 - 1394.
37. 2-adrenoceptor-mediated renal vasoconstriction in conscious rats. Am. J. Physiol., 257, F1132-F1139.